Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2025-04-24 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
董事会审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee regarding the supervision of the accounting firm for the 2024 annual audit. It details the qualifications of the accounting firm, the audit committee's oversight activities, and the approval of the 2024 annual report and related audit supervision report. The document is relatively short (1520 characters) and focuses on the audit committee's evaluation of the auditor's performance and supervision duties, not the full annual report itself. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and results of internal or regulatory oversight related to audits, excluding the full annual report. Therefore, the correct classification is AR with high confidence. FY 2024
2025-04-24 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the seventh meeting of the fourth board of directors of Guangdong Driving Force Biotechnology Group Co., Ltd. It includes summaries of various reports and proposals such as the 2024 annual general manager work report, 2024 board work report, 2024 financial statements, profit distribution plan, and other governance and audit-related reports. The document repeatedly states that the detailed reports are disclosed separately on the Beijing Stock Exchange information disclosure platform with specific announcement numbers. The document is not the full annual report or financial statements itself but a formal announcement of the board meeting decisions and approvals. This fits the definition of Board/Management Information (MANG) as it announces board meeting resolutions and management reports approval. The document length (6492 characters) and content confirm it is not a full financial report but a board meeting resolution announcement.
2025-04-24 Chinese
华安证券股份有限公司关于广东驱动力生物科技集团股份有限公司使用闲置募集资金进行现金管理的核查意见
Regulatory Filings
2025-04-24 Chinese
2024年年度审计报告
Regulatory Filings
2025-04-24 Chinese
独立董事2024年度述职报告（王聪）
Board/Management Information Classification · 95% confidence The document is titled as the "2024年度独立董事述职报告（王聪）" which translates to "2024 Annual Independent Director's Work Report (Wang Cong)". It details the independent director's duties, attendance at board and committee meetings, independence status, protection of investor rights, on-site work, training, and other related activities during the 2024 fiscal year. The content is a detailed report on the independent director's activities and responsibilities rather than a general annual report or financial statement. It does not contain financial statements or audit opinions, nor is it an announcement or proxy material. This type of document fits best under Board/Management Information (MANG) as it relates to board member duties and disclosures about their role and activities.
2025-04-24 Chinese
第四届监事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangdong Driving Force Biotechnology Group Co., Ltd. It details the meeting date, attendance, and voting results on various agenda items including approval of the 2024 Supervisory Board work report, 2024 financial statements, 2024 annual report, profit distribution plan, performance assessment, appointment of accounting firm, use of funds, internal control report, and quarterly report. The document references other detailed reports published separately on the Beijing Stock Exchange information disclosure platform, indicating this document itself is a meeting resolution announcement rather than the full reports. The document length is 3472 characters, which is relatively short and consistent with a meeting resolution announcement. The content focuses on the Supervisory Board meeting decisions and approvals, which aligns with Board/Management Information filings. Therefore, the document is best classified as Board/Management Information (MANG).
2025-04-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.